|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 487/04 | |
| C07C 215/44 | |||
| C07C 217/52 | |||
| C07C 219/24 | |||
| C07C 307/04 |
| (11) | Patento numeris | 2546256 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12172363.9 |
| Europos patento paraiškos padavimo data | 2008-08-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-01-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-10-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 963008 P | 2007-08-02 | US | |
| 62378 P | 2008-01-25 | US |
| (72) |
Armitage, Ian, US
Elliot, Eric L., US
Langston, Marianne, US
Langston, Steven, US
McCubbin, Quentin J., US
Mizutani, Hirotake, US
Stirling, Matthew, US
Zhu, Lei, US
|
| (73) |
MILLENNIUM PHARMACEUTICALS, INC.,
40 Landsdowne Street, Cambridge, MA 02139,
US
|
| (54) | Process for the synthesis of E1 activating enzyme inhibitors |
| Process for the synthesis of E1 activating enzyme inhibitors |